Blueprint (formerly known as HelloJoy), a Chicago, IL-based behavioral health company whose software allows mental health clinicians to efficiently practice measurement-based care (MBC) has raised $1.3M in seed funding led by Lightbank and Hyde Park Angels. The company plans to use the capital to expand its clinician outreach and grow its engineering and sales teams.
Impact of Measurement-based
Care (MBC)
Today, 43 million Americans suffer from a mental illness,
but there are only 28K
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
TriNetX Acquires European Clinical Data Network InSite
TriNetX, a global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE) has acquired Belgium-based Custodix NV and its InSite network. InSite network is a European-based provider of services for clinical trial design, patient feasibility, and enabling workflow for patient recruitment. Financial details of the acquisition were not disclosed.
InSite Clinical Data Network Background
The InSite platform is an
Read More
UM Spinout Fifth Eye Lands $11.5M for Early Warning Patient Deterioration System for Hospitals
Fifth Eye, a medical device software spinoff from the University of Michigan building clinical early warning patient deterioration system for hospitals has raised $11.5 million in Series A funding led by Arboretum Ventures and Cultivation Capital. Other participants in the round include were MINTS, the direct investing arm of the University of Michigan’s endowment, along with additional capital from previous investors Invest Michigan and 35 private angel investors.Why Clinicians Need A Better
Read More
CMS Launches $1.65M Artificial Intelligence Health Outcomes Challenge
This week, the Centers for Medicare & Medicaid Services (CMS) announced the launch of their first-ever Artificial Intelligence Health Outcomes Challenge. The three-stage competition accelerates artificial intelligence (AI) solutions to better predict health outcomes such as unplanned hospital and skilled nursing facility admissions and adverse events for potential use by the Innovation Center in testing innovative payment and service delivery models under the authority of section 1115A of
Read More
Imaware Scientifically Validates At-Home Blood-Testing Platform
In the wake of the Theranos controversy, thousands of consumers were left without a reliable platform for at-home blood testing for chronic illnesses such as Celiac Disease and Rheumatoid Arthritis and other autoimmune diseases.That is why one company decided that they not only needed to make a platform that was accurate but that one where consumers can feel more empowered. imaware, the at-home testing platform for chronic illness and disease, designed by healthcare company Microdrop, has
Read More
Biolinq Lands $4.75M to Expand Biosensor Patch for Continuous Glucose Monitoring
Biolinq, a San Diego, CA-based digital health company developing a minimally-invasive electrochemical biosensor patch for continuous glucose monitoring (CGM) has raised $4.75 million in Series A funding led by the JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners. Existing investors in the round include M Ventures and Hikma Ventures, the corporate venture capital arm of Hikma Pharmaceuticals. The latest round brings Biolinq’s total Series A funding to $15 million.Inception of
Read More
Healthcare M&A: How Carestream Will Change Philips Strategy in Imaging Informatics
Earlier this month, Philips Healthcare announced it had signed an agreement to purchase the IT business (HCIS) of Carestream Healthcare for an undisclosed amount. The deal, expected to close in the second half of the year, is one of the largest M&A moves in the imaging informatics market for some time. While it was one of the worst kept secrets in the industry that the owners of Carestream were looking for a buyer, the decision to split off the HCIS business of Carestream was more of a
Read More
Guardant Health to Acquire Cancer Diagnostic Company Bellwether Bio
Precision oncology company Guardant Health, Inc., announced that it
has entered into a definitive agreement to acquire
Seattle-based Bellwether Bio, an
oncology startup developing next generation cancer diagnostics using cell-free
DNA. The acquisition is expected to close in April 2019. Financial terms of the
acquisition were not disclosed.
Bellwether Bio Background
Spun out of the University of Washington in 2016, Bellwether
Bio (formerly known as Haverhill Genetics) is developing
Read More
Digital Prescribing Platform Xealth Raises $11M to Expand Digital Health Tools
Xealth, a Seattle-based digital prescribing platform has raised $11 million in Series A funding from McKesson Ventures, Novartis, Philips, and ResMed. Existing investors Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network also participated in the round.Xealth BackgroundSpun out of Providence St. Joseph Health in 2017, Xealth enables clinicians to prescribe and monitor digital healthcare content, apps, devices, and
Read More
CHLA Innovation Studio Launches Gamifying Pediatrics Hackathon
The Innovation Studio at Children’s Hospital Los Angeles (CHLA) is launching the first-ever Gamifying Pediatrics Hackathon taking place April 12-14, 2019 at BCG Digital Ventures (BCGDV), the global corporate venture and incubation arm of the Boston Consulting Group. By bringing together physicians and nurses on the front lines of pediatric medicine with engineers, developers, and experts in virtual reality (VR), augmented reality (AR) and gaming, the Hackathon’s aim is to encourage development,
Read More
